Platform overview

One platform from biological discovery to clinical readiness

Our platform bridges high-plex spatial biomarker discovery and routine clinical practice. Decode powers discovery, while Translate, coming soon, will bring promising biomarkers closer to clinical deployment. Together, they help turn scientific findings into diagnostic tests designed for real‑world use.

We're now opening this platform to partners looking to accelerate their own development.

Use cases

  • Responders vs. non‑responders Compare cell neighborhoods between patient groups to find spatial features linked to therapy response.
  • Target expression Map which cells express your target, and which cells sit next to them.
  • Trial patient selection Build a spatial signature that enriches trials for the patients most likely to benefit.
  • Mechanism of action Measure how treatment reshapes cell composition and neighborhoods by comparing tissue before and during treatment.
The Multivision platform
  1. A grid of tissue microarray cores imaged with multiplex immunofluorescence.
    Discovery suite

    Multivision Decode

    From raw high-plex images to phenotypes, spatial ecosystems and patient or sample stratification.

    Explore Decode →
  2. A scientist reviews an IHC-stained tissue section in the viewer.
    Translation suite · Coming soon

    Multivision Translate

    Will turn a high-plex spatial signature into a test that runs on routine IHC with any standard scanner.

    See how we translate →